End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
13.56 USD | -1.31% |
|
-10.14% | 0.00% |
06-24 | Inhibrx Biosciences, Inc.(NasdaqGS:INBX) dropped from S&P Biotechnology Select Industry Index | CI |
05-30 | Inhibrx Biosciences, Inc.(NasdaqGS:INBX) added to S&P TMI Index | CI |
Sales 2022 | 1.32M 103M | Sales 2023 | 1.63M 128M | Capitalization | 196M 15.39B |
---|---|---|---|---|---|
Net income 2022 | -115M -9.02B | Net income 2023 | -155M -12.16B | EV / Sales 2022 * | - |
Net cash position 2022 * | - 0 | Net cash position 2023 * | - 0 | EV / Sales 2023 * | - |
P/E ratio 2022 * |
-
| P/E ratio 2023 * |
-
| Employees | 173 |
Yield 2022 * |
-
| Yield 2023 * |
-
| Free-Float | 0% |
1 day | -1.31% | ||
1 week | -10.14% | ||
Current month | -4.30% | ||
1 month | -16.55% |
![Extreme 13.33](/images/extremecours_fleche.png)
![Extreme 13.33](/images/extremecours_fleche.png)
![Extreme 12.95](/images/extremecours_fleche.png)
![Extreme 12.95](/images/extremecours_fleche.png)
![Extreme 12.95](/images/extremecours_fleche.png)
![Extreme 12.95](/images/extremecours_fleche.png)
![Extreme 12.95](/images/extremecours_fleche.png)
Date | Price | Change | Volume |
---|---|---|---|
02/07/24 | 13.56 | -1.31% | 173,880 |
01/07/24 | 13.74 | -3.03% | 239,286 |
28/06/24 | 14.17 | +0.78% | 823,828 |
27/06/24 | 14.06 | -3.83% | 267,516 |
26/06/24 | 14.62 | -3.11% | 161,704 |
End-of-day quote Nasdaq, July 01, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
0.00% | 196M | |
+2.88% | 93.97B | |
+6.58% | 41.61B | |
-13.20% | 33.32B | |
+77.12% | 28.8B | |
-16.02% | 15.61B | |
-8.17% | 13.27B | |
-12.49% | 11.46B | |
+162.44% | 10.06B | |
-54.92% | 9.09B |
- Stock Market
- Equities
- INBX Stock